Materialise N.V. Technologielaan 15 Heverlee Belgium Match Point System The Match Point System is intended to by uses as a surgical instrument to assist in the intraoperative positioning of glenoid components used with total and reverse shoulder arthroplasty by referencing anatomic landmarks of the shoulder that are identifiable on preoperative CT-image scans. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Match Point System The Match Point System is intended to by uses as a surgical instrument to assist in the intraoperative positioning of glenoid components used with total and reverse shoulder arthroplasty by referencing anatomic landmarks of the shoulder that are identifiable on preoperative CT-image scans.
Brand
Materialise N.V. Technologielaan 15 Heverlee Belgium
Lot Codes / Batch Numbers
ID #s: 804-03-057, 804-25-148, 804-03-058, 804, 07, 022 UDI #s: E314804030570, E314804251480, E314804070220
Products Sold
ID #s: 804-03-057, 804-25-148, 804-03-058, 804,07,022 UDI #s: E314804030570, E314804251480, E314804070220
Materialise N.V. Technologielaan 15 Heverlee Belgium is recalling Match Point System The Match Point System is intended to by uses as a surgical instrument to assist due to The procedure side indicated in the top header of the Shoulder Case Planning Report incorrectly indicated the procedure side as "Left" for surgical pl. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
The procedure side indicated in the top header of the Shoulder Case Planning Report incorrectly indicated the procedure side as "Left" for surgical plans for a "right" procedure side.
Recommended Action
Per FDA guidance
The firm, materialise, sent Recall letters dated 17 July 2020 informing customers of the issue. This letter informs the customer that Materialise has corrected the Shoulder Case Planning Report in the SurgiCase online system. If you have any questions, contact Global Quality and Regulatory Manager Medical, at 734-259-7017 or email: Jenny.Jones@materialise.com.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026